Avanos Medical Future Growth
Future criteria checks 0/6
Avanos Medical is forecast to grow revenue at 4.6% per annum.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Medical Equipment earnings growth | 14.3% |
| Revenue growth rate | 4.6% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 31 Oct 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 756 | N/A | N/A | N/A | 1 |
| 12/31/2025 | 713 | N/A | N/A | N/A | 3 |
| 12/31/2024 | 685 | N/A | N/A | N/A | 3 |
| 9/30/2024 | 682 | 22 | 37 | 56 | N/A |
| 6/30/2024 | 682 | 7 | 42 | 62 | N/A |
| 3/31/2024 | 680 | -2 | 13 | 31 | N/A |
| 12/31/2023 | 673 | -10 | 15 | 32 | N/A |
| 9/30/2023 | 682 | -11 | 37 | 53 | N/A |
| 6/30/2023 | 683 | 9 | 35 | 53 | N/A |
| 3/31/2023 | 684 | 18 | 64 | 82 | N/A |
| 12/31/2022 | 684 | 22 | 72 | 91 | N/A |
| 9/30/2022 | 696 | 23 | 90 | 109 | N/A |
| 6/30/2022 | 708 | -23 | 86 | 104 | N/A |
| 3/31/2022 | 723 | 10 | 72 | 92 | N/A |
| 12/31/2021 | 587 | -31 | 66 | 87 | N/A |
| 9/30/2021 | 736 | -52 | 15 | 36 | N/A |
| 6/30/2021 | 738 | 2 | -5 | 14 | N/A |
| 3/31/2021 | 715 | -38 | -21 | N/A | N/A |
| 12/31/2020 | 715 | -29 | -23 | -2 | N/A |
| 9/30/2020 | 720 | 14 | -30 | -6 | N/A |
| 6/30/2020 | 705 | -17 | -51 | -24 | N/A |
| 3/31/2020 | 714 | -22 | -100 | -57 | N/A |
| 12/31/2019 | 698 | -46 | -125 | -74 | N/A |
| 9/30/2019 | 678 | -42 | -139 | -79 | N/A |
| 6/30/2019 | 671 | -27 | -194 | -130 | N/A |
| 3/31/2019 | 660 | -17 | -247 | -195 | N/A |
| 12/31/2018 | 652 | -8 | -195 | -146 | N/A |
| 9/30/2018 | 649 | -1 | -118 | -74 | N/A |
| 6/30/2018 | 634 | -16 | N/A | 17 | N/A |
| 3/31/2018 | 622 | -28 | N/A | 134 | N/A |
| 12/31/2017 | 612 | -32 | N/A | 144 | N/A |
| 9/30/2017 | -171 | -150 | N/A | 125 | N/A |
| 6/30/2017 | 76 | -130 | N/A | 152 | N/A |
| 3/31/2017 | 327 | -112 | N/A | 183 | N/A |
| 12/31/2016 | 566 | -83 | N/A | 189 | N/A |
| 9/30/2016 | 1,584 | 44 | N/A | 167 | N/A |
| 6/30/2016 | 1,576 | -435 | N/A | 136 | N/A |
| 3/31/2016 | 1,565 | -434 | N/A | 100 | N/A |
| 12/31/2015 | 509 | -101 | N/A | 98 | N/A |
| 9/30/2015 | 1,612 | -443 | N/A | 115 | N/A |
| 6/30/2015 | 1,631 | 20 | N/A | 120 | N/A |
| 3/31/2015 | 1,656 | 7 | N/A | 162 | N/A |
| 12/31/2014 | 1,672 | 27 | N/A | 148 | N/A |
| 9/30/2014 | 1,664 | 69 | N/A | 184 | N/A |
| 6/30/2014 | 1,675 | 125 | N/A | 222 | N/A |
| 3/31/2014 | 1,677 | 168 | N/A | 210 | N/A |
| 12/31/2013 | 1,678 | 155 | N/A | 224 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 8HH's forecast earnings growth is above the savings rate (1%).
Earnings vs Market: Insufficient data to determine if 8HH's earnings are forecast to grow faster than the German market
High Growth Earnings: Insufficient data to determine if 8HH's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 8HH's revenue (4.6% per year) is forecast to grow slower than the German market (5.5% per year).
High Growth Revenue: 8HH's revenue (4.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 8HH's Return on Equity is forecast to be high in 3 years time